Abstract
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
S Surendran-Nair, K Otwombe, D Josipovic, A Violari, C T Tiemessen, B Laughton, M F Cotton, A Mochan
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Unresolved referenced work
Kept as external metadata until matched
Unresolved referenced work
Kept as external metadata until matched
Tissue reservoirs of HIV
10.1097/coh.0000000000000293 · 2016
Discordance between cerebral spinal fluid and plasma HIV replication in patients with neurological symptoms who are receiving suppressive antiretroviral therapy
10.1086/650538 · 2010
Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral load
10.1097/qad.0b013e328355e6b2 · 2012
HIV encephalitis despite suppressed viraemia: a case of compartmentalized viral escape
10.1258/ijsa.2011.010507 · 2011
HIV-1 is transported into the central nervous system by trafficking infected cells
10.20411/pai.v7i2.524 · 2022
Cognitive dysfunction in HIV patients despite long-standing suppression of viremia
10.1097/qad.0b013e3283354a7b · 2010
HIV cerebrospinal fluid escape and neurocognitive pathology in the era of combined antiretroviral therapy: what lies beneath the tip of the iceberg in Sub-Saharan Africa?
10.3390/brainsci8100190 · 2018
Neurocognitive impairment in HIV-1-infected adults in Sub-Saharan Africa: a systematic review and meta-analysis
10.1016/j.ijid.2013.06.011 · 2013
Prevalence of detectable HIV-DNA and HIV-RNA in cerebrospinal fluid of youth with perinatal HIV and impaired cognition on antiretroviral therapy
10.1097/qad.0000000000003937 · 2024
Early time-limited antiretroviral therapy versus deferred therapy in South African infants infected with HIV: results from the children with HIV early antiretroviral (CHER) randomised trial
10.1016/s0140-6736(13)61409-9 · 2013
Early antiretroviral therapy and mortality among HIV-infected infants
10.1056/nejmoa0800971 · 2008
Laboratory diagnosis of intrathecal synthesis of immunoglobulins: a review about the contribution of OCBs and K-index
10.3390/ijms25105170 · 2024
Asymptomatic cerebrospinal fluid HIV-1 escape: incidence and consequences
10.1093/infdis/jiae555 · 2025
Cerebrospinal fluid HIV-1 escape in patients with neurocognitive symptoms: pooled data from a neuro-HIV platform and the NAMACO study
10.1097/qai.0000000000003189 · 2023
Human immunodeficiency virus type 1 RNA detected in the central nervous system (CNS) after years of suppressive antiretroviral therapy can originate from a replicating CNS reservoir or clonally expanded cells
10.1093/cid/ciy1066 · 2019
The definition of HIV-associated neurocognitive disorders: are we overestimating the real prevalence?
10.1186/1471-2334-11-356 · 2011
Persistent intrathecal immune activation in HIV-1-infected individuals on antiretroviral therapy
10.1097/qai.0b013e31815ace97 · 2008
HIV persistence in the central nervous system during antiretroviral therapy: evidence and implications
10.1097/qad.0000000000002439 · 2019
The blood-brain barrier in systemic inflammation
10.1016/j.bbi.2016.03.010 · 2017
No additional external references are available.